Mizoribine 98.0%(HPLC)
98.0%(HPLC)
Properties
| Vapour pressure | 0.0±2.7 mmHg at 25℃ |
| Assay Purity | >98%(HPLC) |
| Refractive index | 1.795 |
| B pt. | 755.9℃ at 760 mmHg |
| M pt. | 198℃(dec.) |
| Density | 2.06 g/cm3 |
Safety Information
| Hazard Statement(s) | H315 - H319 - H335 - H360 |
| Precautionary Statement | P201 - P302 + P352 - P305 + P351 + P338 - P308 + P313 |
| Symbol |
|
| Signal word | Danger |
| Flash point | 410.9℃ |
| Storage Temp. | 0-10℃ |
| Packaging | Glass Bottle |
Description
Application
Mizoribine has been used in topical treatment to evaluate its effect on ocular surface damage of dry eye in B6 mice subjected to desiccating stress (DS).[1]It has also been used as an inosine monophosphate dehydrogenase (IMPDH) inhibitor to test itsin vivoefficacy.
Purpose
For R&D use onlynot for drug household or other uses.
General Description
Nucleoside antibiotic with cytotoxic and immunosuppressive activity.
Documents
| SDS |
| COA |
| Specification |
| Bulk quote order form |